HOB Biotech Group Corp.,Ltd (SHA:688656)

SHA:688656 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	64.86	63.34	121.63	163.47	153.8	449.86
Trading Asset Securities	-	-	-	-	135.23	5.01
Cash & Short-Term Investments	64.86	63.34	121.63	163.47	289.03	454.87
Cash Growth	-3.52%	-47.92%	-25.60%	-43.44%	-36.46%	673.38%
Accounts Receivable	57.4	56	48.61	41.5	32.38	37.48
Other Receivables	1.03	1	2.41	3.94	5.54	3.66
Receivables	58.44	57	51.02	45.44	37.92	41.15
Inventory	104.82	107.08	111.22	111.22	87.8	68.2
Prepaid Expenses	1.13	0.11	-	-	-	-
Other Current Assets	12.39	8.27	8.25	8.09	8.23	5.75
Total Current Assets	241.64	235.79	292.12	328.21	422.98	569.97
Property, Plant & Equipment	651.17	667.65	705.71	578.68	485.27	259.74
Other Intangible Assets	10.72	11.06	10.08	11.86	12.59	12.17
Long-Term Accounts Receivable	-	-	-	0.05	0.1	0.62
Long-Term Deferred Tax Assets	1.72	2.06	4.13	2.47	1.78	1.63
Long-Term Deferred Charges	9.22	10.4	12.12	11.58	16.25	10.27
Other Long-Term Assets	1.97	4.34	8.65	16.4	5.52	9.52
Total Assets	916.43	931.3	1,033	949.26	944.49	863.92

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	8.38	14.02	44.59	23.91	9.37	9.37
Accrued Expenses	25.47	29.33	37.98	34.98	31.06	29.4
Short-Term Debt	30.02	45.01	105.07	50.02	50.01	20.02
Current Portion of Leases	0.83	1.23	1.1	4.8	5.67	5.51
Current Income Taxes Payable	1.23	1.23	3.33	4.67	1.53	2.33
Current Unearned Revenue	11.65	13.3	12.71	14.62	13.33	13.54
Other Current Liabilities	4.38	4.42	5.16	2.74	41.89	6.01
Total Current Liabilities	81.95	108.54	209.94	135.75	152.86	86.17
Long-Term Debt	-	-	8	-	-	-
Long-Term Leases	1.21	1.15	1.53	1.03	9.74	5.35
Long-Term Unearned Revenue	2.01	1.6	1.2	1.74	2.49	2.4
Long-Term Deferred Tax Liabilities	-	-	-	-	0.04	0
Total Liabilities	85.18	111.3	220.67	138.52	165.13	93.92

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	63.52	63.48	63.06	63.06	63.06	63.06
Additional Paid-In Capital	573.13	566.07	562.98	553.46	550.62	549.35
Retained Earnings	214.49	210.34	205.82	193.92	165.51	157.49
Treasury Stock	-20.01	-20.01	-20.01	-	-	-
Comprehensive Income & Other	0.13	0.13	0.29	0.29	0.18	0.1
Shareholders' Equity	831.25	820.01	812.14	810.73	779.36	770
Total Liabilities & Equity	916.43	931.3	1,033	949.26	944.49	863.92

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	32.07	47.39	115.69	55.86	65.43	30.88
Net Cash (Debt)	32.79	15.95	5.93	107.61	223.6	423.99
Net Cash Growth	-	168.84%	-94.49%	-51.88%	-47.26%	2762.22%
Net Cash Per Share	0.53	0.25	0.09	1.68	3.54	6.89
Filing Date Shares Outstanding	62.72	62.68	62.26	62.72	63.06	63.06
Total Common Shares Outstanding	62.72	62.68	62.26	63.06	63.06	63.06
Working Capital	159.68	127.26	82.18	192.46	270.12	483.8
Book Value Per Share	13.25	13.08	13.04	12.86	12.36	12.21
Tangible Book Value	820.53	808.95	802.06	798.87	766.77	757.83
Tangible Book Value Per Share	13.08	12.91	12.88	12.67	12.16	12.02
Buildings	500.47	499.28	512.37	20.53	20.53	17.34
Machinery	336.48	324.91	337.17	249.06	214.57	167.93
Construction In Progress	0.06	0.06	4.83	422.97	325.75	128.88

Data Source: S&P Global Market Intelligence Last updated: Aug 17, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 9, 2026

Data Sources Report a data error